Drugs / l-LV
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04543695 | Aug 2020 → Jul 2022 | rectal cancer | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | l-LV | “Administration of l-LV (400 mg/m2) and oxaliplatin (85 mg/ m2) by intravenous infusion over 2 h, followed by rapid intravenous infusion (iv) of 5-FU (400 mg/m2) and then slow...” NCT04543695 ↗ |
| Route | Intravenous | “l-LV (400 mg/m2) and oxaliplatin (85 mg/ m2) by intravenous infusion over 2 h” NCT04543695 ↗ |